A carregar...
The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing
OBJECTIVE: In the U.S., genetic testing for maturity-onset diabetes of the young (MODY) is frequently delayed because of difficulty with insurance coverage. Understanding the economic implications of clinical genetic testing is imperative to advance precision medicine for diabetes. The objective of...
Na minha lista:
| Publicado no: | Diabetes Care |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Diabetes Association
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6868460/ https://ncbi.nlm.nih.gov/pubmed/31558549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-0486 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|